Maze TherapeuticsMAZE

13F holders, Q1 2025 (March 31)
68holders
1famous investor
$11.02avg. 13F price*

At the end of Q1 2025, 68 institutions reported holding Maze Therapeutics Inc. (MAZE) in their 13F filings. The largest holders were TRV GP Iv, LLC ($66.9M), Frazier Life Sciences Management, L.P. ($45.5M) and ARCH Venture Management, LLC ($45.4M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Maze Therapeutics Inc.
CUSIP
578784100
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150200 Q1 2025: 68Q1 2025Q2 2025: 75Q2 2025Q3 2025: 94Q3 2025Q4 2025: 143Q4 2025Q1 2026: 165Q1 2026Q2 2026: 161Q2 2026

Total Exit/New Position Q1 2025

InstitutionsTotal Value
New Positions67$441.3M
Exits0$0

Ownership 68 holders

TRV GP Iv, LLC 72.02% New 6,073,958 $66.9M
Frazier Life Sciences Management, L.P. 2.08% New 4,129,001 $45.5M
ARCH Venture Management, LLC 22.00% New 4,120,053 $45.4M
Deep Track Capital, LP 1.17% New 3,269,126 $36.0M
Matrix Capital Management Company, LP 7.88% New 2,486,184 $27.4M
Alphabet Inc. 1.68% New 2,412,471 $26.6M
Foresite Capital Management IV, LLC 20.93% New 2,111,919 $23.3M
a16z Capital Management, L.L.C. 2.67% New 1,702,225 $18.7M
Janus Henderson Group PLC 0.01% New 1,246,370 $14.3M
General Catalyst Group Management, LLC 1.29% New 1,035,910 $11.4M
Alliancebernstein L.P. 0.00% New 1,016,446 $11.2M
FMR LLC 0.00% New 968,383 $10.7M
TRV GP V, LLC 8.37% New 950,800 $10.5M
Casdin Capital, LLC 0.85% New 946,357 $10.4M
Logos Global Management LP 1.83% New 936,914 $10.3M
Woodline Partners LP 0.07% New 929,102 $10.2M
Vanguard Group Inc. 0.00% New 666,554 $7.3M
Harvard Management Co. Inc. 0.62% New 637,528 $7.0M
BlackRock, Inc. 0.00% New 582,588 $6.4M
Bessemer Group Inc. 0.01% New 481,790 $5.3M
Octagon Capital Advisors LP 1.12% New 468,000 $5.2M
HHLR Advisors, LTD. 0.14% New 457,535 $5.0M
Sphera Funds Management LTD. 0.97% New 355,554 $3.9M
Foresite Capital Management V, LLC 4.34% New 345,191 $3.8M
Ikarian Capital, LLC 1.16% New 322,740 $3.6M
Affinity Asset Advisors, LLC 0.46% New 250,000 $2.8M
Geode Capital Management, LLC 0.00% New 212,464 $2.3M
Driehaus Capital Management LLC 0.01% New 132,115 $1.5M
Alyeska Investment Group, L.P. 0.01% New 125,000 $1.4M
Boothbay Fund Management, LLC 0.04% New 96,968 $1.1M
UBS Group AG 0.00% New 88,064 $970K
Charles Schwab Investment Management Inc. 0.00% New 72,305 $796K
Northern Trust Corp. 0.00% New 70,838 $780K
State Street Corp. 0.00% New 64,713 $712K
Ghisallo Capital Management LLC 0.03% New 30,000 $330K
Morgan Stanley 0.00% New 23,893 $263K
Invesco Ltd. 0.00% New 20,552 $226K
Citadel Advisors 0.00% New 20,000 $220K
Marshall Wace, LLP 0.00% New 19,597 $216K
Bank of New York Mellon Corp 0.00% New 17,233 $190K
Oxford Asset Management LLP 0.09% New 17,000 $187K
Barclays PLC 0.00% New 14,644 $161K
Davidson Kempner Capital Management LP 0.00% New 13,670 $151K
Goldman Sachs Group Inc. 0.00% New 13,129 $145K
Nuveen, LLC 0.00% — 11,375 $125K
Susquehanna International Group, LLP 0.00% New 10,608 $117K
JPMorgan Chase & Co. 0.00% New 10,141 $112K
Deutsche Bank AG 0.00% New 8,885 $98K
Rhumbline Advisers 0.00% New 7,235 $80K
Citigroup Inc. 0.00% New 6,216 $68K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% New 5,135 $57K
Wells Fargo & Company 0.00% New 4,693 $52K
Corebridge Financial, Inc. 0.00% New 4,328 $48K
Bank of America Corp. 0.00% New 4,327 $48K
New York State Common Retirement Fund 0.00% New 2,300 $25K
Police & Firemen's Retirement System of New Jersey 0.00% New 2,241 $25K
STRS Ohio 0.00% New 1,600 $18K
Ameritas Investment Partners, Inc. 0.00% New 894 $10K
Legal & General Group Plc 0.00% New 871 $10K
Tower Research Capital LLC (TRC) 0.00% New 834 $9K
Comerica Bank 0.00% New 636 $7K
California State Teachers Retirement System 0.00% New 554 $6K
BNP Paribas Financial Markets 0.00% New 400 $4K
Amalgamated Bank 0.00% New 305 $3K
Royal Bank of Canada 0.00% New 133 $1K
Sterling Capital Management LLC 0.00% New 74 $815
SBI Securities Co., Ltd. 0.00% New 26 $286
Nisa Investment Advisors, LLC 0.00% New 18 $198

"% of holder's portfolio" is MAZE's weight in each manager's 13F, not the share of Maze Therapeutics Inc. the manager owns.